Winton Group LTD Inovio Pharmaceuticals, Inc. Transaction History

Winton Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.79 - $1.91 $2,415 - $5,838	-3,057 Reduced 5.73%	50,270 $41,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $5,067 - $8,985	3,594 Added 7.23%	53,327 $83,000
Q3 2022 Nov 10, 2022	SELL	$1.66 - $2.79 $7,592 - $12,761	-4,574 Reduced 8.42%	49,733 $86,000
Q2 2022 Aug 10, 2022	BUY	$1.44 - $3.98 $18,937 - $52,340	13,151 Added 31.95%	54,307 $94,000
Q1 2022 May 11, 2022	BUY	$2.97 - $5.2 $28,479 - $49,862	9,589 Added 30.38%	41,156 $148,000
Q4 2021 Feb 10, 2022	BUY	$4.99 - $7.46 $17,559 - $26,251	3,519 Added 12.55%	31,567 $158,000
Q3 2021 Oct 28, 2021	BUY	$7.16 - $9.69 $25,561 - $34,593	3,570 Added 14.58%	28,048 $201,000
Q2 2021 Aug 10, 2021	BUY	$6.23 - $10.03 $32,589 - $52,466	5,231 Added 27.18%	24,478 $227,000
Q1 2021 Jul 21, 2021	BUY	$8.81 - $16.96 $4,510 - $8,683	512 Added 2.73%	19,247 $179,000
Q4 2020 Feb 12, 2021	SELL	$8.5 - $12.85 $222,759 - $336,759	-26,207 Reduced 58.31%	18,735 $166,000
Q3 2020 Oct 30, 2020	SELL	$9.57 - $27.05 $1.29 Million - $3.64 Million	-134,570 Reduced 74.96%	44,942 $521,000
Q2 2020 Aug 05, 2020	BUY	$7.14 - $31.69 $1.28 Million - $5.69 Million	179,512 New	179,512 $4.84 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $566M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.